Gilles Brisson
Director/Board Member at INNATE PHARMA
Net worth: 172 405 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hervé Eloi Dominique Brailly | M | 62 | 25 years | |
| Odile Belzunce | F | 44 | 19 years | |
| Yannis Morel | M | 50 | 23 years | |
| Irina Staatz-Granzer | M | 64 | 15 years | |
| Eric Vivier | M | 60 | 25 years | |
| Jean-Yves Blay | M | 61 | 7 years | |
| Véronique Chabernaud | M | 62 | 9 years | |
| Cecile Paillous | M | 59 |
Ethypharm SAS
 Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | 13 years |
| Claire de Saint Blanquat | F | 51 | 4 years | |
| Olivier Martinez | M | 54 | 14 years | |
| Henry Wheeler | M | 40 | 3 years | |
| Pascale Boissel | F | 57 | 4 years | |
| Jacques Brom | M | 59 |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Pascale Augé | M | 53 |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Sonia Quaratino | M | - | 1 years | |
| Frederic Lombard | M | 49 | 3 years | |
| Guillaume Gimonet | M | - | - | |
| Jérôme Wacrenier | M | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Dominique Saint Picq | M | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Nicola Beltraminelli | M | 54 | 2 years | |
| Laurence Megard | M | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Frédéric P. Stévenin | M | 58 |
Financière Verdi Iii
 Financière Verdi Iii Financial ConglomeratesFinance Financière Verdi III is an investment holding private company based in Paris, France. The French company functions as an investment holding company. | - |
| Jérémie Gue | M | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Odile Laurent | F | 63 | 7 years | |
| Charlotte Haas | F | - |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | 14 years |
| Jean-Pierre Bracquemart | M | - |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | 11 years |
| Corinne Fau | F | 62 |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| François Auvigne | M | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Arvind Sood | M | - | - | |
| Eric Drapé | M | 62 |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Sally Bennett | M | 52 | 2 years | |
| Michel Maurice Paris | M | 65 |
Financière Verdi Iii
Financière Verdi Iii Financial ConglomeratesFinance Financière Verdi III is an investment holding private company based in Paris, France. The French company functions as an investment holding company. | - |
| Bénédicte Berardo | M | - |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | 13 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-Jacques Bancel | M | - |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | - |
| François Romagné | M | 60 | 14 years | |
| Jean-Luc Boulnois | M | - | - | |
| Jean-Hugues Louis Lecat | M | - |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | - |
| Laure-Hélène Mercier | F | 46 | 14 years | |
| Bruno Delie | M | - |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | 6 years |
| Pierre F. Dodion | M | 69 | 6 years | |
| Régis Roussel | M | - |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | - |
| Marie Meynadier | M | 63 | 4 years | |
| Stéphane Boissel | M | 56 | 8 years | |
| Philippe Pouletty | M | 65 | 15 years | |
| Marcel Rozencweig | M | 78 | 8 years | |
| Patrick J. Langlois | M | 78 | 12 years | |
| Ekaterina Smirnyagina | M | 58 | - | |
| Joyson Karakunnel | M | 54 | 3 years | |
| Karsten Munk Knudsen | M | 53 | - | |
| Frédérique Brune | M | 58 | - | |
| Tracy Rossin | F | 46 | 3 years | |
| Aadam Hussain | M | - | 1 years | |
| Jean-Charles Soria | M | 53 | - | |
| Frédéric Fougerat | M | 57 |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | - |
| Marcus Schindler | M | 57 | 3 years | |
| Marie-Laure Jeanne Antoinette Pochon | F | 65 | 2 years | |
| Mondher Mahjoubi | M | 65 | 8 years | |
| Danielle Spangler | F | - | - | |
| Nicolai Wagtmann | M | 60 | 3 years | |
| Michael A. Caligiuri | M | 68 | - | |
| Bertrand de Talhouët | M | 58 | - | |
| Al S. Waxman | M | 83 | - | |
| Lars Fruergaard Jorgensen | M | 58 | 6 years | |
| Anne-Sophie Herelle | F | 43 | - | |
| Catherine Moukheibir | F | 64 | 5 years | |
| Maïlys Ferrère | F | 60 | 4 years | |
| Per Gunnar Falk | M | - | - | |
| Caroline Guinet | F | - |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | - |
| Frank Morich | M | 69 | 6 years | |
| Hemanshu Shah | M | 63 | 2 years | |
| Terje Kalland | M | 73 | 3 years | |
| Dave A. Eichler | M | - | - | |
| Philippe Maes | M | 79 | - | |
| Frank Bulens | M | 61 | 9 years | |
| Xavier Moreno | M | 75 |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | - |
| Jean Deleage | M | 83 | 9 years | |
| Jennifer Butler | F | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 77 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gilles Brisson
- Personal Network